Molecular Diagnostics Market Size, Companies and Share
The molecular diagnostics market was valued at $15.42 billion in 2023 and is projected to grow significantly, reaching $25.27 billion by 2032. This expansion corresponds to a compound annual growth rate (CAGR) of 5.3% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5150
Report Highlights
- Instruments and systems accounted for the largest portion of the market, contributing 42% of the total share in 2023.
- Infectious disease applications held a significant 31% share of the market in 2023.
- Point-of-care testing is expected to be the fastest-growing segment, with a projected CAGR of 6.2% during the forecast period.
- North America dominated the market, capturing a 43% share in 2023.
Key Companies in the Molecular Diagnostics Market
- BD (Becton, Dickinson and Company): A global leader in medical technology, BD offers advanced diagnostic systems, including molecular testing platforms for infectious diseases and healthcare-associated infections. Their commitment to innovation enhances patient care through precise diagnostic solutions.
- bioMérieux SA: Known for its expertise in in-vitro diagnostics, bioMérieux specializes in infectious disease diagnostics. The company provides automated systems and molecular diagnostics to laboratories worldwide, focusing on rapid and accurate pathogen identification.
- Bio-Rad Laboratories, Inc.: A trusted name in life sciences and clinical diagnostics, Bio-Rad develops robust molecular testing tools, including instruments, reagents, and software for real-time PCR and genetic analysis.
- Abbott: A leader in healthcare innovation, Abbott’s molecular diagnostics portfolio includes tools for infectious disease detection, oncology, and genetic testing. Their Alinity m platform offers high throughput and accuracy in molecular diagnostics.
- Agilent Technologies, Inc.: Agilent provides analytical instruments and molecular diagnostic solutions for genomics, proteomics, and diagnostics. Their SureSelect target enrichment technology is widely used in NGS-based molecular testing.
- Danaher: Through subsidiaries like Cepheid, Danaher is at the forefront of molecular diagnostics, offering rapid and accurate tests for infectious diseases, including the Xpert product line for point-of-care applications.
- Hologic Inc. (Gen-Probe): Hologic focuses on diagnostics for women’s health, infectious diseases, and oncology. Their Aptima assays and Panther system are widely recognized for molecular testing accuracy and efficiency.
- Illumina, Inc.: A global leader in next-generation sequencing (NGS), Illumina develops cutting-edge molecular diagnostic tools that enable comprehensive genomic analysis for applications in oncology, genetic diseases, and infectious diseases.
- Grifols, S.A.: Known for its contributions to transfusion medicine, Grifols offers molecular diagnostics for blood safety and pathogen detection, ensuring reliable testing in critical healthcare settings.
- QIAGEN: A pioneer in molecular diagnostics, QIAGEN provides solutions for sample preparation, assay development, and testing. Their products are widely used in detecting infectious diseases, cancer, and genetic disorders.
- F. Hoffmann-La Roche, Ltd.: Roche is a major player in molecular diagnostics, particularly in oncology, virology, and genetic testing. Their Cobas platforms are widely used for real-time PCR and NGS-based diagnostics.
- Siemens Healthineers AG: Siemens integrates molecular diagnostics with imaging and automation. Their Atellica portfolio and integrated diagnostic solutions support laboratories in delivering fast and reliable results.
- Sysmex Corporation: Renowned for its hematology expertise, Sysmex also offers advanced molecular diagnostic technologies for oncology and infectious diseases, leveraging innovative genetic analysis tools.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/molecular-diagnostics-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5150
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
